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ABSTRACT 
 
 
MicroCT of Coronary Stents: Staining Techniques for 3-D Pathological Analysis.     
(May 2011) 
Stephen Daniel Darrouzet, B.S., Texas A&M Unversity 
Chair of Advisory Committee: Dr. Fred Clubb, Jr. 
 
 In the area of translational research, stent developers consult pathologists to 
obtain the best and most complete amount of data from implanted test devices in the 
most efficient manner. Through the use of micron-scale computed tomography along 
with post-fixation staining techniques in this study, full volumes of previously implanted 
stents have been analyzed in-situ in a non-destructive manner.  The increased soft tissue 
contrast imparted by metal-containing stains allowed for a qualitative analysis of the 
vessel’s response to the implant with greater sensitivity and specificity while reducing 
beam-hardening artifact from stent struts.   
The developed staining techniques included iodine-potassium iodide, 
phosphomolybdic acid, and phosphotungstic acid, all of which bind to soft tissue and 
improve image quality through their ability to attenuate high energy X-rays.  With these 
stains, the overall soft tissue contrast increased by up to 85% and contrast between 
medial and neointimal layers of the vessel increased by up to 22%.  Beam hardening 
artifact was also reduced by up to 38% after staining.   
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Acquiring data from the entirety of the stent and the surrounding tissue increased 
the quality of stent analysis in multiple ways.  The three dimensional data enabled a 
comprehensive analysis of stent performance, lending information such as neointimal 
hyperplasia, percent stenosis, delineation of vessel wall layers, stent apposition, and stent 
fractures. By providing morphological data about stent deployment and host response, 
this method circumvents the need to make the more traditional histology slides for a 
morphometric analysis. These same data may also be applied to target regions of interest 
to ensure histology slides are cut from the optimal locations for a more in-depth analysis.  
The agents involved in such techniques are readily available in most pathology 
laboratories, are safe to work with, and allow for rapid processing of tissue.  The ability 
to forego histology altogether or to highly focus what histology is performed on a vessel 
has the potential to hasten the development process of any coronary stent.   
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1. INTRODUCTION 
 
1.1 Cardiovascular Disease and the Need for Stents 
 Cardiovascular diseases (CVD) accounted for 34.3% of all deaths in 2006 in the 
United States, making it the leading cause of death (1).  Because of the complex nature 
of the cardiovascular system a multitude of problems can arise during a person’s lifetime 
that can lead to development of CVD.  As a result there are a similarly large number of 
medical devices intended to treat manifestations of CVD in humans.  This study focuses 
on imaging techniques to aid in the development and evaluation of devices intended for 
a specific area of CVD known as atherosclerosis; however, these techniques can also be 
applied in a multitude of other areas.   
 Atherosclerosis is one of the more severe manifestations of CVDs in which lipid 
material collects within the wall of coronary arteries.  This buildup of material can 
reduce the diameter of the vascular lumen and lead to a reduction in (or complete 
cessation of) blood flow affecting the downstream myocardial tissue, which is referred to 
as stenosis.  In the late 1970s balloon angioplasty was developed as a treatment option 
for vessels with such lesions and the procedure included using a catheter with an 
expandable balloon on the end to expand the artery (2).  It was later determined that 
merely expanding the vessel acutely would not be sufficient to maintain a larger vessel 
diameter.  An expandable metallic scaffold (a stent) was developed to be deployed 
around the balloon and left inside the vessel (3).  The permanent nature of the stent 
____________ 
This thesis follows the style of the Journal of the American College of Cardiology.
 2 
allowed the vessel to stay patent for a longer period of time but also promoted a chronic 
inflammatory response from the host.  Nevertheless, stents quickly became the therapy 
of choice for atherosclerosis alongside bypass grafting.  Bypass grafting is a more 
invasive procedure (requiring open heart surgery) compared to catheter-based stent 
deployment and involves removing a segment of the saphenous vein from a patient’s leg 
and grafting it onto the coronary vasculature in order to bypass a blockage.  Since the 
late 1980s when stents were first being deployed, a plethora of stent types have been 
developed with different shapes, materials, deployment techniques, mechanical 
strengths, and drug elution capacities.  These current stents along with future devices in 
development all seek to optimize a variety of parameters dealing with solid mechanics, 
biochemistry, materials science, fluid mechanics, surgical practices, and manufacturing 
techniques.  These various aspects can be tested individually in the lab and as a whole in 
animal studies.   
1.2 Stent Analyses 
In the early design process bench testing can help to determine the mechanical, 
material, and functional properties of a stent through simulations (i.e. computational 
fluid dynamics and finite element analysis), test deployments, and manufacturing 
validations. Computer simulations are useful in determining parameters such as strut 
shape, width, and spacing (4).  While all of these factors are necessary and helpful in 
designing an optimized stent, bench tests such as these cannot fully predict how the 
device will perform when deployed in a real vessel.  Stents are first deployed in a non-
injury animal model to introduce controlled deployment conditions.  Through 
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deployment in living animals one can verify the results of bench testing with more 
representative data; in addition to being able to collect data regarding how the stent will 
affect the physiology of the animal.  While some performance data can be recorded 
about the stent in-vivo the outcome of the stent deployment relies on a pathological 
analysis performed after necropsy of the animal.   
Stent pathology evaluations are routinely made using traditional histology 
procedures.  The vessels of interest are dissected from the test subject and are processed 
for routine paraffin histology, plastic embedded histology, scanning electron microscopy 
(SEM), or transmission electron microscopy (TEM).  Each of these traditional evaluative 
procedures involves examination of selected discrete samples of the stent; whether it is 
perpendicular to the long axis (histology slides) or parallel to the long axis (SEM).  The 
processes involved in performing plastic histology, for example, on a stented vessel are 
not only time consuming, costly, and destructive, but commonly leave large areas of the 
vessel out of the analysis.  In order to gather data from the entirety of a vessel, 3-D 
tomographical imaging techniques can be employed.  However, no current imaging 
technique possesses the sensitivity and specificity that light microscopy-based histology 
can achieve.   The advantage of using a tomographical imaging technique to analyze 
stents is that the amount of data is vastly increased and is more dynamic, allowing slices 
to be taken along the entirety of the stent and from different angles.  Furthermore, many 
imaging techniques are non-destructive, allowing data to be collected without precluding 
the sample from further analysis.  Clinical imaging scanners are not typically used in a 
post-mortem stent evaluation due to the limited resolution of the scanners used.  
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MicroCT uses images of much higher resolutions to provide a more accurate picture of 
the stent’s position and the vessel’s healing response.  Typically microCT is limited to 
detecting failed deployments and fractures in the stent struts and (along with injected 
contrast media) providing data about the lumen of the vessel (5).  MicroCT has also been 
applied to the evaluation of ex-vivo test deployments to help explore the effects of over-
expansion (6).  However, microCT alone lacks the specificity necessary to analyze the 
vascular tissue around an implanted stent.  MicroCT scanners are capable of detecting 
the densities of vessel tissue, but cannot distinguish between different tissue types in a 
vessel due to similar densities. Both metrics are necessary to be able to understand how 
the body is reacting to the implant.   Therefore, microCT alone provides little new 
information other than allowing one to visualize stent fractures, which is merely one 
manifestation of stent failure.  In order to create a more useful microCT stent evaluation 
technique one must understand and be able to characterize the way a vessel responds to 
an implant.   
While stents play an important role in improving blood flow to a patient’s heart 
they are not without risk both during and after implantation.  Two failure modes that are 
linked to the host response are in-stent restenosis and stent thrombosis.  In-stent 
restenosis is a re-narrowing of the vessel due to trauma from the stent implantation (7).  
Stent thrombosis is the formation of a thrombus or a blood clot in the coronary 
vasculature in response to an implanted stent (8).  These two outcomes can occur due to 
procedural problems, manufacturing problems, patient physiology, or intrinsic problems 
with the stent design.  Stent developers in the early design phase can seek to minimize 
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variability in procedures and patient physiology through using skilled and experienced 
veterinary cardiovascular surgeons to implant stents in a non-injury animal model.  
Through controlling the quality of the vessel for implantation as well as the skill of the 
surgeon developers seek to minimize those variables and focus on aspects of the stent 
design that may affect its performance, namely the injury induced to the vessel wall.  By 
varying the number of struts in a stent, the shape of the struts, the strut thickness, and the 
material comprising the stent, the stent may cause different levels of injury to the vessel 
wall (9). The trauma induced spans a continuum from the vessels being stretched around 
the stent into a new geometry to a more serious injury scenario where the strut dissects 
through the vessel wall.  After the implantation procedure, damage to the vessel (or a 
pre-existing lesion, if present) includes denudation of the endothelial lining and possible 
disruption of smooth muscle cells in the media.  The injury can then activate cytokines 
and other chemotaxic factors that serve to activate smooth muscle cell migration and 
proliferation (10).  This proliferation is a necessary step in order for the vessel to 
accommodate the stent and eventually heal; however, if the damage is too great the 
resulting response can be harmful.  When smooth muscle cells proliferate excessively it 
is known as neointimal hyperplasia in general or in-stent restenosis when a stent has 
been implanted. The neointima that forms in response to a stent often lacks uniform 
smooth muscle cell orientation and the wall is often expanded by extra-cellular fluid and 
fibrous connective tissue (10). Depending on the extent of the restenosis the host may be 
able to remove much of the extra-cellular fluid and reduce the level of restenosis.  
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Without such a healing process, the restenosis can require intervention as the 
proliferation can re-occlude the vessel.   
An additional phenomenon that is associated with quickly developing neointimal 
growth is the buildup of para-strut amorphous material (PAM).  After a stent is deployed 
and the endothelial layer of the vessel is damaged, platelets and fibrin can accumulate on 
and around the struts, causing red blood cells to become enmeshed in them.  The 
endothelial layer then proliferates over the stent struts and the mixture of blood 
components coalescing in the adjacent area, trapping it within the neointima (11).  In 
areas of normal neointimal growth this PAM can be cleared out through macrophage 
phagocytosis and digestion of the red blood cells.  In thicker areas of neointimal growth 
macrophages can take a much longer time to reach the PAM and digest the red blood 
cells, leaving pools of red blood cells near the struts.  The other main adverse outcome 
of stent implantation is the generation of a thrombus due to the stent’s presence.  Stent 
thrombi typically begin with the aggregation of platelets and can occur due to a variety 
of reasons such as changing hemodyamics in the area around the stent struts or the stent 
material being wholly or partially non-biocompatible.  While all of the mechanisms that 
can lead to a thrombus forming are not well understood there are several patient factors 
such as diabetes mellitus or resistance to aspirin, and also lesion characteristics such as a 
particularly long or complex lesion (i.e. bifurcated) that predispose to stent thrombosis 
(8).  Additionally, case-specific implantation complications that can occur include: 
inappropriate stent sizing and/or expansion, incomplete stent apposition in the vessel, or 
penetration of a necrotic core.  While patient factors such as these are relatively 
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unchangeable, developers seek to minimize the hemodynamic changes around the stent 
as well as to prevent poor deployments or stent fractures.  Often when biocompatibility 
appears to be causing problems stent developers will make use of drug-eluting stents 
coatings while using other materials already being employed in other stents.  However, 
in cases where a new material is being used, even if very similar to other materials, the 
host could react negatively to the implant.  In these cases the device must go through 
multiple animal trials in order to minimize the host reaction.  In order to show a stent can 
produce a healthy level of neointima while producing no thrombi the stent must be 
implanted for a given time and then evaluated by a pathologist.  Therefore, pathological 
evaluations of stents tend to focus on identifying weak points in a stent trial to elucidate 
problems with the stent design. 
1.3 Alternative Imaging Techniques 
The traditional means of assessing the efficacy of a stent’s design and 
implantation focus on determining the success of the deployment and the level of neo-
intimal hyperplasia.  Assessing a proper deployment involves knowing where the stent is 
located and being able to visualize the struts to see if they are structurally sound in 
relation to the vessel.  Measuring the level of neo-intimal hyperplasia involves 
determining where the medial layer of the vessel ends (i.e. the internal elastic lamina) 
and how thick the neointimal layer is.  Deployment evaluations are presently 
accomplished in-vivo through techniques such as intravascular ultrasound (IVUS)(12), 
angiography (13), magnetic resonance imaging (MRI) (14), computed tomography (CT) 
(14), and optical coherence tomography (OCT) (15).  Ex-vivo analyses then involve 
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traditional histology procedures such as embedding the vessel in plastic and generating 
microscope slides for analysis.  This slide making technique involves serial sectioning 
wherein a predetermined number of slides are made from each stent, limiting the 
analysis to several two-dimensional images.  While a large number of slides can be made 
so as to include representative regions of the whole length of the stent, it is both costly 
and time consuming, leading most developers to make roughly three to five slides.  The 
slides are then assumed to be representative of the areas of the stent between.  This small 
sample provides an incomplete understanding of the stent’s performance.  SEM can be 
used to assess the level of damage to the endothelial layer of the vessel at a given time 
point by allowing the topography of the inner surface of the vessel to be imaged.  
However, SEM can be expensive, time consuming, and can prevent the tissue from 
being analyzed in another fashion (i.e. normal cross-sectional histology slides).  SEM 
provides little data about the level of neointima and other components of the vessel wall.  
The in-vivo methods mentioned above can be used in a post-mortem stent analysis as 
well, but not without limitations of their own.  Intravascular ultrasound has been found 
to lack specificity in distinguishing between tissue types in the vessel wall, in addition to 
having artifacts induced by dense the metal struts (16).  This modality is therefore 
limited to gross morphological and stent apposition evaluations.  While OCT produces 
finer resolution images than IVUS, it also suffers from strut artifacts and is limited to 
imaging tissue depths of 1mm (15).  Using wavelengths of light near the visible range, 
OCT is able to determine proper strut coverage and re-endothelialization in-vivo, 
however, the penetration depth limitation of OCT can prevent a complete stent analysis 
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(15).  If the neointimal growth in the vessel is too thick for light from the catheter to 
reach the medial layer of the vessel proper neointimal measurements cannot be made. 
Angiography can provide some information about the extent of the neo-intimal 
hyperplasia by using injected contrast media and in some instances identify fractures in 
the stent.  But it is unable to determine where the medial layer of the vessel is and often 
lacks resolutions necessary for proper evaluation.  Clinical CT and MRI are not typically 
used for metallic stent evaluations due to the high level of artifacts associated with each 
imaging modality and the relatively poor resolution compared to the scale of the stented 
vessel.   
1.4 MicroCT Basics and Advantages 
To understand how staining soft tissue with radiopaque agents increases both the 
sensitivity and specificity of a microCT, one must understand how CT and radiographic 
images are made.  CT and plane-film radiographic data are collected by detecting 
differing levels of attenuated X-ray photons generated by a controlled X-ray source.  
After being generated from an electron beam aimed at a target (i.e tungsten), X-rays 
spanning a range of energy levels pass through the sample and strike a flat panel detector 
(i.e. amorphous silicon) which collects the X-ray radiation and outputs varying levels of 
visible light based on the remaining energy and amount of X-ray photons after being 
attenuated by the material.  A charge-coupled device (CCD) then detects the photons and 
converts the data into digital form, creating a digital image of the sample based on the X-
ray attenuation values.  The attenuation of X-ray photons is a function of the electron 
density of the various elements contained within the material the photons are passing 
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through (17).  The data collection for radiography and CT is therefore related to the 
electron density of the elements comprising the object in addition to the object’s physical 
density.  Thus, materials with relatively low electron density and physical density, such 
as most soft tissues, do not attenuate X-rays to a great extent making it difficult for 
scanners to detect and differentiate between various tissues.   
High density materials pose an additional problem during the CT scanning 
process.  Artifacts induced during a CT scan with a metal object occur due to a 
phenomenon called beam hardening.  Beam hardening is a process by which the average 
energy of a beam of X-ray photons increases as it passes through tissue (16).  This 
increase is possible because many X-ray sources produce a poly-energetic spectrum of 
X-rays.  When the spectrum of X-ray photons pass through an object, lower energy X-
rays can become absorbed by the material, only allowing higher energy photons to pass 
through, increasing the average energy of the remaining X-rays.  In cases where X-rays 
must penetrate a highly dense material such as stainless steel or calcium, many low 
energy X-ray photons will be absorbed.  Depending on the thickness and the type of 
material, enough photons can be absorbed so that only a small fraction of higher energy 
X-ray photons pass through to the detector.  It is therefore advantageous to increase the 
starting maximum energy level of the X-ray source to produce a larger number of high 
energy photons that are capable of penetrating through the dense material.  However, as 
the X-ray energy level increases, soft tissue attenuation decreases.  The high energy 
photons that are able to pass through the material then register a low attenuation from the 
soft tissue on the opposite side of the material (18).  Therefore, increasing the X-ray 
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energy reduces artifact from metal objects but also diminishes the signal obtained from 
surrounding soft tissue.  Radiopaque staining agents can be used to allow soft tissue to 
better attenuate the high energy X-rays that are necessary to penetrate a high-density 
material contained within the soft tissue.  Since the late 1980s, there has been much 
work to reduce or eliminate beam hardening artifacts during or after the reconstruction 
process (19)(20).  With these techniques relying largely on post-processing techniques, 
there is the possibility of losing some data or having it be interpolated incorrectly (21).   
While increasing the X-ray kiloVoltage (kV) during a CT scan helps minimize 
such artifacts by allowing more photons to penetrate the denser material, it also reduces 
soft tissue contrast.  Therefore, by using radiopaque stains that contain high electron 
density metals to artificially increase the electron density of the soft tissue, microCTs 
can be performed on soft tissue with metallic implants at high energy levels.  Because 
the radiopaque staining agents bind to different tissue types with greater or lesser 
affinities, contrast between different tissue types is possible (Figure 1).    
Similar staining agents to the ones evaluated in this study have been used for the 
purpose of enhancing soft tissue contrast in studies of mouse and chicken models.  A 
variety of different contrast agents, including iodine-potassium iodide (I-KI), 
phosphotungstic acid (PTA), and osmium tetroxide (OsO4) have been used to highlight 
various types of embryonic tissue (22).  The staining agents used mainly function by 
binding to lipids (cell membranes), intracellular proteins, or extracellular proteins and 
therefore impart a general level of radiopacity relative to the various tissue densities in 
the tissue (23).  Other studies have made use of these agents to create high-contrast 
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images of small vertebrates and insects (24), rat nephrons (25), rat muscle tissue (26), 
and pig lungs (27).  Post-fixation techniques using similar agents have been created in 
this study to increase soft tissue contrast and reduce artifacts in coronary vessels 
containing metallic stents.   
Applying post-fixation stains to soft tissue creates a greater sensitivity of the 
scanner by causing the soft tissue to attenuate more X-ray photons.  The stains are all 
commonly used in histology and gross evaluations and have affinities for slightly 
different molecules, cell types, and tissues.  The relatively heavy metals contained in the 
stains (iodine, tungsten, molybdenum) are then able to attenuate higher energy X-rays. 
Because of the binding targets of the stains, the various tissue types contained in a vessel 
are imparted with different amounts of radiopacity.  I-KI or “Lugol’s Iodine” is typically 
used to identify larger polysaccharides at the gross level such as starch-like materials and 
lipids (28).  PTA is a common chemical used in conjunction with hematoxylin in a 
PTAH fibrin stain along with the similar chemical PMA.  These two acidic chemicals 
are used to stain tissues such as collagen fibers, red blood cells, and muscle fibers (29).  
PMA has a known lower affinity for binding to tissue while the molybdenum atoms 
contained in each molecule have a lower electron density and therefore are not as 
effective at attenuating X-rays.  The radiopaque stains can also be combined in order to 
produce more attenuation under microCT.  When PTA or PMA is placed in a solution of 
water and EtOH for staining purposes, some of the molecules dissociate into a phosphate 
group and a tungsten (or molybdenum) group.  This dissociation lowers the amount of 
intact PTA or PMA molecules that can bind to the tissue.  By combining the two 
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chemicals in a 2:1 (PTA:PMA) ratio, the PMA is allowed to dissociate, saturates the 
solution with phosphate groups, which then allows more PTA to bind to the tissue.  
Additionally, using PTA and PMA to stain tissue first, followed by I-KI staining, can 
potentially create a large increase in overall radiopacity with the maximum amount of 
tissue being stained.   
While the staining agents may have different binding properties, the staining 
process functions by attaching heavy metals to proteins, lipids, and other molecules in 
the tissue.  The metal that is deposited is then much more radiopaque than the tissue 
itself and causes a larger amount of photons to be attenuated to a greater extent.  This 
greater attenuation increases the soft tissue contrast during microCT.  By scanning the 
full volume of the stent after staining, various regions of tissue in the vessel along with 
the structure of the implanted stent itself can be evaluated from the same dataset. 
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2. MATERIALS AND METHODS 
 
2.1  Materials 
Research was carried out at the Texas A&M University Cardiovascular 
Pathology Laboratory in College Station, Texas in cooperation with the Department of 
Biomedical Engineering and the Department of Veterinary Pathobiology.  The study 
included porcine iliac vessels with implanted metal stents as part of a separate study 
(AUP#:2005-102). This project was carried out between October of 2010 and March of 
2011.  The following is a description of the materials and equipment used in this 
research project. 
All porcine samples were received from necropsy having been fixed in-situ using 
10% neutral buffered formalin (NBF) in plastic specimen jars.   Samples were scanned 
using an X-Tek HAWK 160XI combined X-ray and microCT scanner (made by Nikon 
Metrology, Inc.).  The raw microCT data was then transferred via external hard drive to 
a dedicated reconstruction computer.  The computer made use of proprietary 
reconstruction software (CT-Pro) to generate microCT datasets, which were then viewed 
using VGStudioMAX (made by Volume Graphics, GmbH).  Reconstructed volumes 
contain CT numbers on a 16-bit color scale, with values ranging from 0 to 65,536.   
Samples were stained with three chemicals:  I-KI (aqueous solution), PTA 
(aqueous solution), and PMA (solid crystal in solution) in different concentrations and in 
different base solutions depending on the chemical.  In processing for microground 
histology, samples were dehydrated using ethyl alcohol (EtOH) and then infiltrated with 
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technovit 7200, a methyl methacrylate light-activated polymer.  Sample preparation 
made use of a shaker table, dessicator, and light-polymerizer.  Slides were then cut and 
ground using a diamond band saw and microgrinder system (made by EXAKT GmbH).  
The slide staining process made use of formic acid, ethyl alcohol, Scott’s tap water, 
Gibb’s hematoxylin, eosin, and phyloxine B to produce a traditional H&E stain on a 
plastic slide.   
Slides were scanned into digital format using a Nikon Super Cool Scan 9000.  
Unstained material within slides was sent to the Texas Heart Institute at the University 
of Texas Medical School at Houston for analysis using an XLT ultramicrotome to cut 
samples, toluidine blue, basic fuchsin, uranyl acetate, and lead citrate to stain the 
samples, and a JEOL 1230 electron microscope with an AMT 600 digital camera to 
image the samples.  Slide images and microCT data were analyzed using ImageJ (NIH) 
image analysis software, Image-Pro (Media Cybernetics) software, and Microsoft Excel 
(Microsoft Corp.).   
2.2 Selection of Radiopaque Staining Chemicals 
In order to carry out this research, chemicals were first selected and tested based 
on their safety, cost, and effectiveness before being applied to the stented vessels for this 
study.  OsO4 was eliminated as a possibility due to the high cost of the chemical in 
addition to its high toxicity even in small amounts.  I-KI, PTA, and PMA were therefore 
chosen for the project.  In addition to testing the chemicals alone, combined stains of 
PTA & PMA and PTA, PMA, & I-KI were evaluated.   
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2.3  Individual Staining Trials 
Before testing each chemical on stented vessels increasing concentrations of each 
chemical were used to stain non-stented porcine vessel tissue.  In order to quickly 
determine the relative level of radiopacity added by each chemical radiographs were 
taken before and after each trial and at different time points during the staining process.   
Each staining chemical was tested on its own at first, followed by combination stains.  
For the PTA staining trials the tissue was first dehydrated to 70% EtOH due to the 
evidence showing the PTA stain has been shown to function best in that solution (29).  
PTA solutions of 0.5%, 1%, and 5% in 70% EtOH were prepared and the samples were 
placed in the chemical over night.  At 24 and 48 hours of staining radiographs were 
taken of each sample at the same X-ray power settings.  A similar process was used for 
the analysis of PMA as a staining chemical.  0.5%, 1%, and 5% solutions were prepared 
and images were collected at 24 and 48 hours.  For I-KI, the staining process included no 
EtOH and the samples were stained in an aqueous solution of 5% I-KI, 10% I-KI, and 
10% I-KI with additional added potassium iodide (KI) to buffer the solution.  Samples 
were stained for and imaged at 24 and 48 hours.   The radiographic images collected 
were then analyzed in ImageJ.  Contrast percent for this study was calculated as follows: 
Contrast Percent =  (AUO – AUB) 
               (AUO – AUB)/2 
 
where AUO is the arbitrary unit gray value for the object, and AUB is the arbitrary unit 
gray value for the background.  In addition to the contrast percent (Table 1), images 
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were inspected visually to qualitatively judge the increased specificity created by the 
stain in different parts of the tissue.   
Table 1. Staining concentration trials
0.5%  Stain Measured 
Contrast    Percent
1% Stain Measured
Contrast Percent
5% Stain Measured 
Contrast Percent
PTA Test Sample 19 51 57 
PMA Test Sample 16 23 27
I-KI Staining concentration trials
5% Stain Measured 
Contrast Percent
10% Stain Measured 
Contrast Percent
10% with 5g KI Stain 
Measured Contrast 
Percent
I-KI Test Sample 29 59 45
 
After such analysis it was determined that 3% PTA, 3% PMA, and 10% I-KI 
were optimal staining concentrations.  A concentration of 3% was chosen for the PTA 
and PMA samples due to the fact that the 1% stain had not imparted enough stain to the 
vessels yet a 5% stain caused the solution to dehydrate the tissue to a large extent and 
caused shrinkage of the vessel.   
Prior to staining stented porcine vessels for this study each vessel had been fixed 
in 10% NBF.  Unstained scans were then completed at 150kV and 134 µAs with an 
8mm aluminum plate used to pre-harden the X-ray beam.  Approximately 1000 
projections were taken per vessel, creating an average resolution 18µm.  After scanning 
and reconstruction of each unstained vessel, the vessels were stained according to the 
optimal staining procedure determined previously.  Vessels were removed from staining 
chemicals and placed in a plastic sample pouch filled with either 70% EtOH or distilled 
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water in order to prevent dehydration during the scanning process.  All vessels were then 
placed in 70% EtOH and processed for plastic microground histology. 
In comparing staining times between the different staining trials, it was noted that 
the stains containing PTA and/or PMA required at least 48 hours of staining time to 
sufficiently penetrate the majority of the tissue.  Initially, the I-KI stain was performed 
on this same timescale, however due to a perceived faster staining time a second I-KI 
trial was initiated in which the staining process was more closely monitored over time. 
Thus, another advantage of the I-KI stain was found to be its ability to penetrate the soft 
tissue of the vessels in roughly 3 hours. 
2.4  Combined Staining Trials 
 In order to explore possible advantages of combining some of the staining 
chemicals, given that they have slightly different binding affinities, combination stains 
were tested and analyzed alongside the individual staining trials.  A PTA & PMA stain 
in a ratio of 2:1 was compared with the 3% PTA and 3% PMA data due to PMA’s ability 
to provide buffer for PTA and allow more stain to bind to the tissue.  Additionally, all 
three chemicals were combined in a trial to explore differences in the types of tissue 
being stained within a single sample.  Vessels were prepared by performing a microCT 
scan prior to staining.  The vessels were then stained with the combinations PTA & 
PMA and PTA, PMA & I-KI using 3% PTA, 1.5% PMA, and 10% I-KI.  Vessels were 
removed from staining chemicals and placed in a plastic sample pouch filled with either 
70% EtOH or distilled water in order to prevent dehydration during the scanning 
process.  The vessels were scanned using the same power settings (150 kV, and 
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134µAs), taking approximately 1000 projections and resulting in an average resolution 
of 18µm.  The vessels were then placed in 70% EtOH and processed for plastic 
microground histology. 
2.5 Volume Analysis 
 Upon completion of the reconstructions the microCT volumes were analyzed 
using VGStudioMAX and Image-Pro.  The scans were visualized in three different slice 
views as well as a 3-D rendered volume.  The 3-D volume allows for better visualization 
of the shape of the vessel and stent as a whole, whereas the slice views were used to 
create comparable images for validation with histology.  The volumes of each vessel 
were analyzed for regions of interest (ROIs) that were representative of the sample. 
Average CT numbers were calculated from ROIs of the background (air), neointima, 
media, stent struts, and areas of high stain uptake in the vessel wall.  Slices of the stent 
with identifiable areas of stent deformation, high levels of neo-intimal hyperplasia, or 
other sites of high stain uptake were taken note of and targeted for histology.  The axial 
slices that contained these areas of interest were exported from the program and saved as 
Joint Photographic Experts Group (JPEG) image files.  In addition to axial slice images 
showing the stained soft tissue surrounding the stent struts, images of the same slice with 
the density window adjusted to the full width at half maximum (FWHM) of the stent 
strut data were collected.  A similar analysis was performed on the unstained sample 
data with average CT numbers being calculated from ROIs generated approximately in 
the neointima and media.  The stained images were then imported into Image-Pro 
software, which enables measurements to be taken on the images.  The measurement 
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function of the software was calibrated by using the images showing the stent struts at 
FWHM (Figure 2) which were manufactured to be 150µm.  The calibration made use of 
the FWHM view of the struts in order to approximate the size of the stent struts.  Lumen 
circumference, stent circumference and medial circumference measurements were taken 
as a means to compare the quantitative capabilities of microCT slice data for stent tissue 
analysis (Figure 3).  An example of the measurements is shown in Table 2.   
Table 2.  Measurement data from histology and microCT images
Histology Slide 
Measurements (mm)
MicroCT Slice Data 
Measurements (mm)
Lumen Circumference 
(Red Circle) 
9.19 7.95  
Stent Circumference 
(Yellow Circle)
16.08 14.95
Media Circumference 
(Green Circle)
17.34 15.84
 
2.6  Plastic Histology 
After completion of the staining and scanning process for each of the 5 vessels, 
the tissue continued the dehydration process in preparation for plastic histology.  The 
samples were placed on a shaker table in graded alcohols until 99% was reached.  The 
vessels were then infiltrated with the liquid form of a light polymerizing methyl 
methacrylate, Technovit 7200 (Exact) by graded infiltration in EtOH.  After standard 
infiltration times for stented vessels, they were placed in a light polymerizer to harden 
the polymer.  Slides were then cut from the embedded tissue using an EXACT diamond 
band saw system.  The slides chosen were based on the areas of interest as seen in the 
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microCT data and were cut as close to those regions of interest as possible.  The slides 
were then ground to a useful thickness ranging from 25-75µm.  Once polished, some 
slides maintained their radiopaque chemical stain and did not require histological 
staining, others were stained using an H&E staining protocol developed for plastic 
histology.   
2.7  Histological Analysis 
In order to validate the microCT data and ensure that the various areas of tissue 
shown in the microCT data are representative of the tissue, the histology slides were 
analyzed using the same morphometric parameters as the microCT slice data.  Using a 
Nikon Super Cool Scan 9000 digital versions of each slide were made at 2x 
magnification.  For calibration a standardized micrometer slide was scanned and 
digitized in the same fashion.  The images were stored as JPEGs and imported into 
Image-Pro software for analysis.  Using the calibration slide image to ensure the 
measurements were accurate the lumen circumference, stent circumference, and medial 
circumference were measured and tabulated (Table 2).  Additionally, the areas of high 
stain uptake identified in microCT slice data were brought to pathologists for 
identification.  Due to the microCT staining agents interfering with the H&E histology 
staining of some cellular types, some areas were not able to be identified.  These samples 
were then taken to the Texas Heart Institute for TEM analysis.  Slides containing high 
radiopaque stain uptake material that could not be stained with H&E stains were 
analyzed with a JEOL 1230 electron microscope (JEOL USA, Inc.) and images captured 
with an AMT 600 digital camera.  The samples were prepared by identifying an area of 
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interest and removing it from the slide, which was then placed in plastic resin from 
which thick (1µm) and thin (80-90nm) sections were cut on an ultramicrotome.  Thick 
sections were stained with toluidine blue and basic fuchsin.  Thin sections were mounted 
on 100 mesh copper grids and stained with uranyl acetate and lead citrate.  The sections 
were then examined on an electron microscope.  The resulting TEM images were then 
reviewed by a pathologist with experience in vascular TEM analysis for identification of 
the material.   
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3.  RESULTS 
 
3.1 Layout of Analysis 
There were many aspects of this study that must be examined in order to make 
decisions about the utility of the proposed techniques.  The radiopaque stains aim to 
increase the sensitivity and specificity of the microCT process in an efficient and non-
destructive manner.  It is therefore necessary to compare the stains to each other through 
the relative radiopacity they impart to the vessels.  Furthermore, the radiopaque stains 
must be compared to the resulting histology through their ability to stain certain tissue 
types representatively.  Additionally, the stains must be evaluated for their speed of 
staining and the vessel’s ability to still be used in traditional histology if desired.  
Through exploring the strengths and weaknesses of the staining chemicals one can 
determine the most useful microCT staining technique.   
The staining process must itself be verified and shown to have increased the 
radiopacity of the vessel while also decreasing the level of metal streaking artifact.  An 
increase in radiopacity is measured by comparing the contrast level in ROIs from the 
stained data to similar ROIs in the unstained data.  The level of artifact present before 
and after scanning is represented by the change in standard deviation of the CT numbers 
detected within the metal of the stent and its adjacent volume.  After comparing the level 
of radiopacity added to the vessel tissue the stains can then be compared to each other in 
order to determine which chemicals increase the soft tissue contrast to a larger extent.   
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3.2 Contrast Increase Due to Staining 
After calculating contrast levels within the stained and unstained data sets, the 
contrast percent increase was calculated for each stain trial (Table 3).   
Table 3. Summary of contrast increase after 48 hours of staining
PTA PMA I-KI PTA & PMA PTA, PMA, & I-KI
Neointima Contrast 
Increase
28% 21% 64% 56% 63%
Media      Contrast 
Increase
57% 31% 85% 73% 85%
Strut CT Number 
Standard Deviation 
Decrease
32% 15% 38% 28% 36%
 
By looking at the values in table 3, one can see that all of the stains helped to 
increase the contrast of the vessel, however not all stains were able to differentiate 
sufficiently between tissue types, namely the media and neointima of the vessel.  The 
standard deviation of the CT numbers in the area surrounding the stent strut are 
representative of whether the stained tissue surrounding the stent struts is able to 
attenuate the scattered X-ray photons thereby masking the scattered photons.  The PTA 
stain provided a 57% increase in the contrast of the medial layer of the vessel and was 
able to clearly delineate the lumen of the vessel (Figure 4).  The standard deviation of 
the CT numbers surrounding the struts in the PTA stain decreased by 32% after staining, 
indicating that there was a significant drop in the level of metal artifact.  The PMA stain 
showed a slight increase in contrast overall, but did not allow for a clear distinction 
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between media and neo-intima (Figure 5).  In figure 5 the left image shows that the PMA 
stain was also unable to penetrate the full thickness of the tissue, despite having been 
allowed to stain the tissue for 48 hours.  Furthermore the PMA stain decreased the 
standard deviation of the CT numbers by the lowest amount, causing metal artifact 
streaks to remain.  The I-KI stain was able to increase the soft tissue contrast of the 
vessel by 85% for the media and allowed for a large decrease in the level of metal 
artifact (Figure 6).  The 48 hour I-KI stain, while proving to be a powerful tool for aiding 
in microCT data collection also prevented the tissue from being sectioned with plastic 
histology.  The 3 hour I-KI stained vessel was placed back in formalin upon completion 
of the scan, which removed the I-KI from the tissue and allowed for normal plastic 
histology (Figure 7).  The combined PTA & PMA stain was able to increase the contrast 
of the tissue overall, provided better contrast than the PTA or PMA stains alone, and 
reduced the metal artifact roughly the same amount as the PTA stain alone.  However, 
this combined stain did not produce as much of a contrast change between the media and 
neointima (Figure 8).  Finally, the combined PTA/PMA/I-KI produced a similar contrast 
increase to the I-KI stain alone, and it was able to reduce the metal artifact roughly the 
same amount.  This would suggest that the I-KI solution possibly replaced the PTA and 
PMA staining molecules in the tissue.  However, as with the other I-KI sample, the stain 
was not removed prior to processing and thus the tissue was not penetrated properly for 
plastic histology (Figure 9).     
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The axial slices and measurements of each vessel’s scan data were compared 
with the histology slides and measurements.  In order to accurately measure histology 
slides that had been digitized by a Nikon Super Cool Scan 9000 digital slide scanner a 
calibration slide was used to set the exact number of millimeters per pixel (mm/pixel) for 
all slides scanned with the scanner.  Because of technical complications with spatial 
calibrations of the microCT scanner, the CT slice data was similarly calibrated from the 
FWHM axial view images to be 150µm.  The CT slices analyzed were captured at the 
slice most closely approximating where the histology slides were cut in order to ensure 
the most appropriate juxtaposition of measurements.  CT and histology measurements 
were compared plotted against one another in Microsoft Excel where a linear regression 
showed a close correlation between the slice data measurements (Figure 10).   
The variations between the measurements can be partially attributed to the 
staining process itself and whether or not the samples were dehydrated before scanning.  
Samples stained with I-KI were stained in an aqueous solution whereas the PTA and 
PMA samples were stained in a 70% EtOH solution, partially dehydrating the tissue and 
causing shrinkage.   The highly acidic nature of PTA and PMA solutions may also have 
caused a higher level of tissue shrinkage during the staining process that was then 
rectified when the tissues were processed for histology.  There is also some geometric 
distortion affecting the measurements wherein both the microCT scanning process and 
the plastic histology process are not able to produce slices perfectly perpendicular to the 
long axis of the stent.  The slight angles that both the histology slides and microCT slices 
were taken at may have then skewed the measurements slightly.  Even with such 
3.3 Verification with Histology 
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variations when compared to histology, the ability to take such measurements from 
every slice in a volume of CT data allows this method to be a useful qualitative tool for 
identifying areas of concern and interest within a stented vessel.   
3.4 Detection of PAM 
It was also noted in analyzing the microCT data that in places of high neointimal 
proliferation there were high levels of stain uptake in both the acid based stains and the 
iodine-based stains (Figure 11).  These areas were not able to be stained with normal 
histology chemicals (Figure 11).  This lack of normal staining is perhaps due to the 
chemical changes that took place during the microCT staining process.  In order to 
identify the material samples were sent to THI for TEM analysis, which showed the 
areas to be pools of red blood cells having formed next to the stent struts, indicating the 
areas contained PAM (Figure 12).  These areas had some of the highest affinities for 
both PTA and I-KI and therefore had increased contrast levels compared to the other 
types of tissue (25% above that of the media).  Because not all the samples in this study 
contained such material, the relative abilities of each stain to detect PAM in the vessel 
wall could not be included in as a method of comparing each staining technique.  
However, the ability to detect such material could be evaluated at a future time.   
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4. DISCUSSION AND CONCLUSION 
 
 The process of fine-tuning a device to optimize the performance after 
implantation can involve multiple animal studies, all of which must be analyzed by a 
pathologist.  By maximizing the amount of data from animal studies one can help to 
minimize the cost and time between design changes and therefore minimize the time to 
market for the next generation of any device.  The power of using the described 
microCT staining techniques is in the ability to rapidly perform a full analysis of the 
tissue in a non-destructive way.  While the resolution of microCT has not achieved that 
of light microscopy and therefore cannot be used as a diagnostic tool for individual cell 
types, qualitative characterization of the stent remains a useful form of analysis.  The 
ability to gather data from the entirety of the stent and analyze it for medial dissections, 
stent apposition problems, stent fractures, etc. allows one to quickly distinguish between 
neointimal hyperplasia due to a medial dissection or due to an intrinsic design flaw.  In 
cases where a problem occurs that is external to the stent design (i.e. poor stent 
apposition), identification of that problem through microCT could lower the need to 
perform traditional histology on the vessel, thereby saving both time and money by 
avoiding a histological analysis that would yield little or no useful data.   
After analyzing the effectiveness of the various staining methodologies, it is clear 
that I-KI is the most useful and rapid stain.  The tissue, once fixed in formalin, can be 
placed directly into the I-KI solution with no dehydration required.  The stain time for I-
KI to penetrate roughly 2mm of vessel tissue was found to be 3 hours.  Taking into 
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account staining, scanning, and reconstruction, the total time to perform a full microCT 
analysis of the entirety of the stent is approximately 5 hours.  The vessel can then be 
placed back in formalin over night to remove the I-KI and can then be dehydrated and be 
prepared for traditional plastic histology.  By comparison, the dehydration process alone 
for a stented vessel in plastic histology can take 8 hours with the rest of the process 
requiring days before slides can be analyzed.  One of the disadvantages of using I-KI is 
its relative lack of specificity when other tissues are involved.  Because I-KI binds 
readily to lipids, any sample with excessive fatty tissue surrounding the area of interest 
can become saturated and obstruct the distinction between the layers of the vessel wall.  
This phenomenon could become a problem in human samples that contain larger 
amounts of lipid material.  Therefore, in cases where there is a large amount of 
extraneous tissue surrounding the sample, the PTA stain would be preferable due to the 
high amount of contrast added to the tissue and its lack of ability to stain lipids.   
  A further powerful use of such staining techniques stems from the identification 
of PAM within the vessel wall.  Being able to characterize and possibly quantify the 
level of red blood cells captured in the para-strut areas after implantation could help to 
understand the way PAM develops and the way it heals over time.  Additionally, with 
the knowledge of how effectively the staining chemicals are taken up by red blood cells, 
one would be able to analyze stented vessels that are difficult if not impossible to be 
analyzed through other CT methods.  When post-mortem blood remains in the vessel 
lumen after dissection traditional CT methods of imaging are not possible due to the 
inability to inject contrast media into the lumen and the inability to distinguish blood 
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from the vessel wall.  Furthermore, the possibility of distinguishing between post-
mortem blood and thrombi in the vessel would be possible through this technique, 
removing yet another reason for vessels to undergo traditional histology.  Other possible 
diagnostic capabilities of such techniques include identification of areas of necrosis or 
fibrosis, but these remain to be tested in the future.   
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APPENDIX 
 
 
Figure 1. Effects of Staining on Stented Vessels 
MicroCT slice images of before (left) and after (right) radiopaque staining 
techniques to show the increased quality of data through staining.     
 
 
 
 
 Figure 2.  Slice Images Used for Calibration 
MicroCT slice images showing just the metal struts at FWHM (left) for calibration  
of Image-Pro and the same slice with the tissue being displayed (right) for 
measurements. 
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Figure 3.  Measurements of Histology and MicroCT Slice Data 
Images showing technique for comparing measurements between histology and 
microCT slices.  The circles shown on the pictures are representative of where the 
measurements were taken and correspond to the measurements in table 6.   
 
 
 
 
Figure 4.  PTA Staining for 48 Hrs 
Comparison of histology (left) and microCT slice view (right) of a vessel having been 
stained with PTA.  
  
PTA PTA 
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Figure 5.  PMA Staining for 48 Hrs 
Comparison of histology (left) and microCT slice view (right) of a vessel having  
been stained with PMA.  The microCT slice view highlights the inability of PMA to 
sufficiently increase the soft tissue contrast to mask the metal streaking artifacts.  
 
 
 
 
Figure 6.  I-KI Staining for 48 Hrs 
Comparison of histology (left) and microCT slice view (right) of a vessel having been 
stained with I-KI.  The I-KI stain was not removed before processing for histology and 
thus there is some artifact from the I-KI interfering with the embedding process.  
 
PMA PMA 
I-KI I-KI 
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Figure 7.  I-KI Staining for 3 Hrs 
Comparison of histology (left) and microCT slice view (right) of a vessel having  
been stained with I-KI for 3 hours.  The vessel was placed in formalin after scanning  
and allowed to sit for 24 hours before being processed for histology.  The speed and 
utility of this technique is most clearly demonstrated here.   
 
I-KI I-KI 
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Figure 8.  PTA & PMA Staining for 48 Hrs 
Comparison of histology (left) and microCT slice view (right) of a vessel having been 
stained with PTA and PMA.  Of note, the stain also was able to detect nerve tissue in 
 the bottom left corner.   
 
 
 
 
Figure 9.  PTA, PMA, & I-KI Staining for 48 Hrs 
Comparison of histology (left) and microCT slice view (right) of a vessel having been 
stained with PTA, PMA, and I-KI sequentially.  The I-KI stain was not removed before 
processing for histology and thus, there is some artifact from the I-KI interfering with 
the embedding process. 
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Figure 10.  Correlation between Slice Measurements 
Histology and microCT slice data measurements show the  
ability of microCT to provide accurate morphological data. 
 
 
 
 
Figure 11.  PAM Detected in the Vessel Walls 
Both the PTA (left) and I-KI (right) based stains were able to detect PAM within 
 the vessel wall.  The areas of high stain uptake between and around the stent struts  
are visible in the microCT slice (white blotches) and in the histology slide (gray 
blotches) in areas of high neointimal growth.   
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Figure  12.  TEM Identification of PAM  
TEM image captured of the PAM present in the  
vessel wall.  There are red blood cells present  
along with macrophages.   
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